Antisense Oligodeoxyribonucleotides Inhibit the Expression of the Gene for Hepatitis B Virus Surface Antigen

References

1. Alexander J., Bey E., Whitcutt M., Gear J. 1976; Adaptation of cells derived from human malignant tumours to growth in vitro . South African Journal of Medical Sciences 41:89–95
   [Google Scholar]
2. Beasley R. P., Lin C. C., Hwang J.-Y., Chen C. S. 1981; Hepatocellular carcinoma and hepatitis B virus, a progressive study of 22707 men in Taiwan. Lancet ii:1129–1133
   [Google Scholar]
3. Chisari F. V., Klopchin K., Moriyama T., Pasquinelli C., Dunsford H. A., Sell S., Pinkert C. A., Brinster R. L., Palmiter R. D. 1989; Molecular pathogenesis of hepatocellular carcinoma in HBV transgenic mice. Cell 59:1145–1156
   [Google Scholar]
4. Chomczynski P., Sacchi N. 1987; Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162:156–159
   [Google Scholar]
5. Eckstein F. 1985; Nucleoside phosphorothioates. Annual Review of Biochemistry 54:367–402
   [Google Scholar]
6. Ganem D. 1982; Persistent infection of humans with hepatitis B virus: mechanisms and consequences. Review of Infectious Diseases 4:1026–1047
   [Google Scholar]
7. Goodchild J., Agrawal S., Civeira M. P., Sarin P., Sun D., Zamecnik P. C. 1988; Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides. Proceedings of the National Academy of Sciences, U.S.A 85:5507–5511
   [Google Scholar]
8. Gunning P., Ponte P., Okayama H., Engel J., Blau H., Kodes L. 1983 Molecular and Cellular Biology 3:787–795
   [Google Scholar]
9. Hollinger F. B., Melnick J. L., Robinson W. S. 1985 Viral Hepatitis New York: Raven Press;
   [Google Scholar]
10. Knowles B. B., Howe C. C., Aden D. P. 1980; Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209:497–499
    [Google Scholar]
11. Macnab G. M., Alexander J. J., Lecatsas G., Bey E. M., Urbanowicz J. M. 1976; Hepatitis B surface antigen produced by a human hepatoma cell line. British Journal of Cancer 34:509–515
    [Google Scholar]
12. Matsukura M., Zon G., Shinozuka K., Stein C. A., Mitsuya H., Cohen J. S., Broder S. 1988; Synthesis of phosphorothioate analogues of oligodeoxyribonucleotides and their antiviral activity against human immunodeficiency virus. Gene 64:343–347
    [Google Scholar]
13. Maupas P., Melnick J. L. 1981; Hepatitis B infection and primary liver cancer. Progress in Medical Virology 27:1–5
    [Google Scholar]
14. Moriarty A. M., Hoyer B. H., Shih J. W., Gerin J. L., Hamer H. 1981; Expression of the HBV surface antigen gene in cell culture by using a simian virus 40 vector. Proceedings of the National Academy of Sciences, U.S.A 78:2606–2610
    [Google Scholar]
15. Ono Y., Onda H., Sasada R., Igarashi K., Sugino Y., Nishioka K. 1983; The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw. Nucleic Acids Research 11:1747–1757
    [Google Scholar]
16. Quinn T. C., Piot P., Mccormick J. B., Feinsod F. M., Taelman H., Kapita B., Faaci A. S. 1987; Serologic and immunologic studies in patients with AIDS in North America and Africa. Journal of the American Medical Association 257:2617–2621
    [Google Scholar]
17. Rivkina M. B., Lunin V. G., Mahov A. M., Tikchonenko T. I., Kukain R. A. 1988; Nucleotide sequence of integrated hepatitis B virus DNA and human flanking regions in the genome of the PLC/PRF/5 cell line. Gene 64:285–296
    [Google Scholar]
18. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual, 2nd edn. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
19. Seto E., Benedict T. S., Peterlin M., Ou J.-H. 1988; Transactivation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proceedings of the National Academy of Sciences, U.S.A 85:8286–8290
    [Google Scholar]
20. Stein A., Cohen J.-S. 1988; Oligodeoxynucleotides as inhibitors of gene expression. Cancer Research 48:2659–2668
    [Google Scholar]
21. Szmuness W. 1988; Recent advances in the study of the epidemiology of hepatitis B. American Journal of Pathology 81:629–649
    [Google Scholar]
22. Tiollais P., Pourcel C., Dejean A. 1985; The hepatitis B virus. Nature; London: 317489–495
    [Google Scholar]
23. Twu J.-S., Robinson W. S. 1989; Hepatitis B virus X gene can trans-activate heterologous viral sequences. Proceedings of the National Academy of Sciences, U.S.A 86:2046–2050
    [Google Scholar]
24. Walder R. Y., Walder J. A. 1988; Role of RNase H in hybrid-arrested translation by antisense oligonucleotides. Proceedings of the National Academy of Sciences, U.S.A 85:5011–5015
    [Google Scholar]
25. Zamecnik P. C., Goodchild J., Taguchi Y., Sarin P. 1986; Inhibition of replication and expression of human T-cell lympho- tropic oligonucleotides complementary to viral RNA. Proceedings of the National Academy of Sciences, U.S.A 83:4143–4146
    [Google Scholar]